Silencing of SOCS1 in murine melanoma cells resulted in Smads 2/3 and Smads 1/5/8 activation, simultaneously with the increased expression of MMPs in B16F10-Nex2 murine melanoma cells, by a non-canonical pathway. The gene discussed is SOCS1; the disease is melanoma.